Antisense-based therapy salanersen (BIIB115/ION306) is a possible follow-up to Biogen's big-selling Spinraza (nusinersen) therapy for SMA, which has come under pressure from increased competition in ...

Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

More than 8 million people globally suffer from type 1 diabetes, a condition where the immune system destroys ...

Testosterone therapy did not improve walking distance in older women recovering from hip fracture compared to exercise alone, ...

Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades from the South African Medical Research Council for their groundbreaking ...

Hibiscus, ginger, garlic, cinnamon, and other herbs may help lower blood pressure naturally. Practical tips can help you add ...

Comparator drug sourcing isn’t simply an operational task—it’s a core component of trial planning. A well-executed sourcing ...

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is currently recommended in current ...

Basel: Novartis has announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. With the ...

Senior doctors will be balloted on pay offer The BMA has announced indicative ballots of senior doctors in England, asking whether they are willing to take industrial action over their recent 4% pay ...

The non-alcoholic steatohepatitis (NASH) clinical trials market is estimated to generate a market size of USD 2.96 billion in ...